Latest Multidisciplinary Association for Psychedelic Studies Stories
On September 21, nonprofit scientific and educational organization the Multidisciplinary Association for Psychedelic Studies (MAPS) will commemorate 25 years of groundbreaking research into the
This September, the nonprofit research and education organization Multidisciplinary Association for Psychedelic Studies (MAPS) celebrates the launch of its new Canadian affiliate, MAPS Canada,
SANTA CRUZ, Calif., July 18, 2011 /PRNewswire-USNewswire/ -- On July 15, 2011, U.S. District Judge William Pauley III sentenced a defendant charged with selling Ecstasy to 26 months in prison, less than half the 63 to 78 months recommended by current sentencing guidelines.
WASHINGTON, March 9, 2011 /PRNewswire-USNewswire/ -- On Monday, March 7, Professor Lyle Craker, Director of the Medicinal Plant Program at the University of Massachusetts-Amherst, filed the final brief in his ten-year fight to persuade the Drug Enforcement Administration to allow him to grow marijuana for medical research.
SANTA CRUZ, Calif., Feb. 15, 2011 /PRNewswire-USNewswire/ -- Today the journal Addiction published online the results of a neuroscience study finding no evidence of impaired cognitive performance in users of Ecstasy, the street name for the chemical known as MDMA.
MDMA (Â±3,4-methylenedioxymethamphetamine, also known as Ecstasy), may one day offer hope for individuals with posttraumatic stress disorder (PTSD), even people for whom other treatments have failed.
While ecstasy became infamous as a drug taken at night clubs or during parties, new research suggests that it might help those suffering from post-traumatic stress disorder (PTSD).
LSD is back in labs after years of disrepute, joining other hallucinogens as legitimate subjects of research, a researcher in Santa Cruz, Calif., said. The first new studies of LSD in human subjects started at Harvard University last year.
- A person in a secondary role, specifically the second most important character (after the protagonist).